Waaree Energies delivered a landmark FY26: revenue ₹26,537 crore (+84%), PAT ₹3,884 crore (+101%), EBITDA ₹5,909 crore (22.27% margin), order book ₹53,000 crore, ROCE 32.4%. Non-Chinese status + US manufacturing = global trade war moat. FY27 EBITDA ₹7,000-7,700 crore — cell integration (H2 FY27) drives the next margin step-up. Good sentiment, high confidence (order book visibility, structural trade advantages, cell integration catalyst).

Headline Numbers

Metric FY26 Notes
Revenue ₹26,537 crore +83.7% YoY
Operating EBITDA ₹5,909 crore 22.27% margin
PAT ₹3,884 crore +100.6% YoY
Order Book ~₹53,000 crore ~2 years visibility
Module Capacity ~26 GW —
ROCE 32.4% —
FY27 EBITDA Guidance ₹7,000-7,700 crore Cell integration catalyst
Cell Capacity (FY27) 15.4 GW H2 FY27 ramp

What Drove the Results

  • Revenue +84% — India's solar capacity addition + US export boom: India added record solar capacity in FY26 (50+ GW target) with Waaree supplying modules to large IPPs (Adani Green, NTPC Renewable, ReNew). Simultaneously, US export demand surged as IRA benefits (domestic content bonus) and Chinese tariffs made Waaree's modules preferred. The combination of domestic boom + US export ramp created the 84% growth. This is not cyclical — India has a 500 GW renewable target by 2030 and the US has permanent IRA incentives through 2030.
  • PAT doubling (+101%) — operating leverage + premium pricing for non-Chinese modules: Waaree's cost structure (largely fixed manufacturing + variable cells/glass) means revenue doubling at constant margins doubles operating profit. But Waaree also earns a premium: non-Chinese, IRA-compliant modules command 5-15 cents/W premium in the US vs. comparable Chinese-made panels. This premium is structural as long as US-China trade tensions persist — creating above-normal margins vs. Chinese peers.
  • Order book ₹53,000 crore — execution, not demand, is the constraint: With ₹53,000 crore of orders and ~₹26,537 crore in FY26 revenue, Waaree has 2x revenue in backlog. The only question is: can they execute? Execution requires: module production ramping to 26 GW+, cell integration running in H2 FY27, and US manufacturing facility scaling. No demand uncertainty — the constraint is operational capacity.
  • EBITDA margin 22.27% — premium for scale + non-Chinese + IRA compliance: Waaree's 22% EBITDA margin is among the highest for solar module manufacturers globally. This reflects the IRA-eligible premium on US modules, India's low manufacturing cost, and scale (26 GW = procurement leverage on glass, EVA, backsheet). Cell integration (H2 FY27) adds another 2-4% margin improvement — explaining the ₹7,000-7,700 crore EBITDA guidance at potentially flat revenue growth (quality over quantity).
  • ROCE 32.4% — exceptional capital returns for manufacturing: A 32.4% ROCE for a capital-intensive manufacturer (solar modules require significant plant and equipment) is exceptional. This reflects: (1) premium ASP for non-Chinese/IRA modules, (2) strong operating leverage on fixed manufacturing costs, (3) working capital efficiency (order-backed production — not speculative inventory). The Waaree 2.0 capex ($3.5 billion) will temporarily dilute ROCE while capacity is being built — but steady-state ROCE post-integration should be even higher.

What Management Said

Management was confident and strategic. On FY26: "₹26,537 crore revenue, PAT doubled — this validates our positioning in the global solar value chain. Non-Chinese status is a permanent advantage." On FY27 EBITDA: "₹7,000-7,700 crore EBITDA guidance — cell integration in H2 FY27 is the primary driver. Every GW of cell capacity eliminates 40-50% of that cell's cost from our input purchases." On trade war: "We are one of the largest beneficiaries of the US-China trade war. Our US manufacturing (Waaree Inc.) is IRA-compliant — domestic content bonus is real revenue." On order book: "₹53,000 crore order book — 2 years of visibility. We are not demand-constrained; we are capacity-execution-constrained." On risks: "ALMM II policy clarity from India government is awaited. Commodity cost (glass, polysilicon) and logistics volatility in Q4 temporarily compressed margins — normalising in FY27."

Key Tailwinds and Risks

Tailwinds:

  • Non-Chinese solar manufacturer at scale — permanent structural advantage in US and EU markets
  • IRA (US Inflation Reduction Act) — 30% ITC + domestic content bonus driving US demand for Indian solar
  • India's 500 GW renewable target by 2030 — domestic capacity addition creating sustained demand
  • Cell integration H2 FY27 — 2-4% EBITDA margin expansion from backward integration
  • ALMM II policy clarity — could mandate domestic module content, benefiting Waaree vs. imports

Risks:

  • Execution risk — Waaree 2.0 capex ($3.5 billion) requires flawless project management
  • Commodity and logistics cost volatility — Q4 FY26 margins temporarily compressed; could recur
  • ALMM II delay — regulatory uncertainty impacting India domestic order flow timing
  • US policy risk — IRA rollback or modification could reduce US export premium
  • Polysilicon supply from China — Waaree still imports polysilicon; supply disruption risk

StockMirror AI Signal Summary

Signal Reading
Overall Sentiment Good
Management Confidence High
Prepared Remarks Good — 84% growth milestone, FY27 EBITDA guidance, trade war moat
Q&A Sentiment Good — confident on cell integration catalyst, candid on commodity risks
Revenue Growth Exceptional — 84% FY26; 2-year order book visibility
Margin Direction Improving — 22.27% EBITDA; cell integration adds 2-4% in H2 FY27
Earnings Quality Strong — ROCE 32.4%; non-Chinese premium; order-backed production

Track Waaree Energies' full AI earnings breakdown — cell integration progress, order book execution, and US manufacturing ramp — at Waaree Energies' earnings page.

Key Takeaways

  • FY26 revenue ₹26,537 crore (+84%); PAT ₹3,884 crore (+101%); EBITDA ₹5,909 crore (22.27%)
  • Order book ₹53,000 crore (~2 years visibility); module capacity 26 GW; ROCE 32.4%
  • Non-Chinese status + US IRA-compliant manufacturing = structural global trade advantage
  • FY27 EBITDA ₹7,000-7,700 crore — cell integration (15.4 GW) in H2 FY27 is the margin catalyst
  • Waaree 2.0 capex $3.5 billion — backward integration to cells, glass, polysilicon

Frequently Asked Questions

What is Waaree Energies' FY26 revenue and growth? Waaree Energies reported FY26 revenue of ₹26,537 crore (+83.7% YoY), PAT of ₹3,884 crore (+100.6%), and EBITDA of ₹5,909 crore (22.27% margin). Order book: ~₹53,000 crore. Module manufacturing capacity: ~26 GW. ROCE: 32.4%. FY27 EBITDA guidance: ₹7,000-7,700 crore, driven by cell integration in H2 FY27.

Why does Waaree Energies benefit from the US-China trade war? Waaree is a non-Chinese solar manufacturer. The US has imposed 145% tariffs on Chinese solar modules under USTR Section 301 — effectively pricing Chinese competition out of the American market. Waaree's US manufacturing facility (Waaree Inc.) produces IRA-compliant modules eligible for domestic content bonuses worth 10-30 cents/W. This creates a structural premium vs. non-US manufacturers and a permanent exclusion for Chinese competitors.

What is Waaree's cell integration strategy and its impact on margins? Currently Waaree buys solar cells (the semiconductor heart of a module) and assembles them into modules. Cell costs are 40-50% of total module cost. Waaree 2.0 adds 15.4 GW of cell manufacturing capacity — ramping in H2 FY27. Cell integration eliminates the cell purchase cost, directly improving EBITDA margins by 2-4 percentage points. This is the primary driver of FY27 EBITDA guidance (₹7,000-7,700 crore) exceeding FY26 EBITDA (₹5,909 crore) despite potentially flat ASPs.

Related: Adani Green Energy Q4 FY26 · Sterling Wilson Solar Q4 FY26 · Skipper Q4 FY26

Disclaimer: This article is for informational purposes only and does not constitute investment advice. StockMirror's AI analysis is based on publicly available earnings transcripts and BSE/NSE filings. Please consult a SEBI-registered financial advisor before making investment decisions.